37538397|t|Identification and characterization of putative biomarkers and therapeutic axis in Glioblastoma multiforme microenvironment.
37538397|a|Non-cellular secretory components, including chemokines, cytokines, and growth factors in the tumor microenvironment, are often dysregulated, impacting tumorigenesis in Glioblastoma multiforme (GBM) microenvironment, where the prognostic significance of the current treatment remains unsatisfactory. Recent studies have demonstrated the potential of post-translational modifications (PTM) and their respective enzymes, such as acetylation and ubiquitination in GBM etiology through modulating signaling events. However, the relationship between non-cellular secretory components and post-translational modifications will create a research void in GBM therapeutics. Therefore, we aim to bridge the gap between non-cellular secretory components and PTM modifications through machine learning and computational biology approaches. Herein, we highlighted the importance of BMP1, CTSB, LOX, LOXL1, PLOD1, MMP9, SERPINE1, and SERPING1 in GBM etiology. Further, we demonstrated the positive relationship between the E2 conjugating enzymes (Ube2E1, Ube2H, Ube2J2, Ube2C, Ube2J2, and Ube2S), E3 ligases (VHL and GNB2L1) and substrate (HIF1A). Additionally, we reported the novel HAT1-induced acetylation sites of Ube2S (K211) and Ube2H (K8, K52). Structural and functional characterization of Ube2S (8) and Ube2H (1) have identified their association with protein kinases. Lastly, our results found a putative therapeutic axis HAT1-Ube2S(K211)-GNB2L1-HIF1A and potential predictive biomarkers (CTSB, HAT1, Ube2H, VHL, and GNB2L1) that play a critical role in GBM pathogenesis.
37538397	83	106	Glioblastoma multiforme	Disease	MESH:D005909
37538397	219	224	tumor	Disease	MESH:D009369
37538397	294	317	Glioblastoma multiforme	Disease	MESH:D005909
37538397	319	322	GBM	Disease	MESH:D005909
37538397	586	589	GBM	Disease	MESH:D005909
37538397	772	775	GBM	Disease	MESH:D005909
37538397	994	998	BMP1	Gene	649
37538397	1000	1004	CTSB	Gene	1508
37538397	1006	1009	LOX	Gene	4015
37538397	1011	1016	LOXL1	Gene	4016
37538397	1018	1023	PLOD1	Gene	5351
37538397	1025	1029	MMP9	Gene	4318
37538397	1031	1039	SERPINE1	Gene	5054
37538397	1045	1053	SERPING1	Gene	710
37538397	1057	1060	GBM	Disease	MESH:D005909
37538397	1158	1164	Ube2E1	Gene	7324
37538397	1166	1171	Ube2H	Gene	7328
37538397	1173	1179	Ube2J2	Gene	118424
37538397	1181	1186	Ube2C	Gene	11065
37538397	1188	1194	Ube2J2	Gene	118424
37538397	1200	1205	Ube2S	Gene	27338
37538397	1220	1223	VHL	Gene	7428
37538397	1228	1234	GNB2L1	Gene	10399
37538397	1251	1256	HIF1A	Gene	3091
37538397	1295	1299	HAT1	Gene	8520
37538397	1329	1334	Ube2S	Gene	27338
37538397	1346	1351	Ube2H	Gene	7328
37538397	1409	1414	Ube2S	Gene	27338
37538397	1423	1428	Ube2H	Gene	7328
37538397	1543	1547	HAT1	Gene	8520
37538397	1548	1553	Ube2S	Gene	27338
37538397	1560	1566	GNB2L1	Gene	10399
37538397	1567	1572	HIF1A	Gene	3091
37538397	1610	1614	CTSB	Gene	1508
37538397	1616	1620	HAT1	Gene	8520
37538397	1622	1627	Ube2H	Gene	7328
37538397	1629	1632	VHL	Gene	7428
37538397	1638	1644	GNB2L1	Gene	10399
37538397	1675	1678	GBM	Disease	MESH:D005909
37538397	Association	MESH:D005909	3091
37538397	Association	MESH:D005909	4318
37538397	Association	MESH:D005909	27338
37538397	Association	MESH:D005909	7428
37538397	Association	27338	8520
37538397	Association	MESH:D005909	4016
37538397	Association	MESH:D005909	710
37538397	Association	MESH:D005909	4015
37538397	Association	MESH:D005909	5351
37538397	Association	MESH:D005909	5054
37538397	Association	7328	8520
37538397	Association	MESH:D005909	7328
37538397	Association	MESH:D005909	649
37538397	Association	MESH:D005909	1508
37538397	Association	MESH:D005909	8520
37538397	Association	MESH:D005909	10399

